What they were paid
Insight Molecular Diagnostics Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $85,427 | $106,400 | $0 | $0 | $191,827 |
| FY2024 | $77,177 | $0 | $74,187 | $0 | $151,364 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Insight Molecular Diagnostics Inc. DEF 14A filed April 30, 2026, accession 0001493152-26-020502, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Insight Molecular Diagnostics pays directors a $85,427 cash retainer and $106,400 in RSUs.
The rest of the Insight Molecular Diagnostics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Andrew Arno | Chair of the Board | $312,627 |
| Andrew J. Last | Independent Director | $191,827 |
| Joshua Riggs | Director | $0 |
The full Insight Molecular Diagnostics compensation record
free company briefThis page is one director within Insight Molecular Diagnostics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat